Advertisement

Topics

Friedli Corporate Finance Company Profile

01:09 EST 19th December 2018 | BioPortfolio

Friedli Corporate Finance was started by Peter Friedli in 1986. Since then Peter Friedli has raised Venture Capital from over 80 banks, pension funds and corporations mainly in Switzerland. He has invested in the areas of biotechnology and technology predominantly in the US. The services provided range from corporate structuring and investing to general management. Friedli Corporate Finance is an investment firm with a unique business philosophy.
Objective
Friedli Corporate Finance's mission is to discover, structure, invest and manage the ideas and technologies that will be at the forefront of the industries in the next decade. We provide a unique investment access to early stage high quality companies to achieve substantial capital appreciation through active management involvement in a diversified investment universe. Our success depends on recognizing and executing our unique approach to investing in Venture Capital which enables our clients to benefit through the expertise, integrity and professionalism to realize maximum returns on their investment.

Location

Freigutstrasse 5,
Zurich
Schlieren
8002
Switzerland

Contact

Phone: 41.44.283.29.00
Fax: 41.44.283.29.01
Email: peter.friedli@friedlicorp.ch


News Articles [507 Associated News Articles listed on BioPortfolio]

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

Virbac: Availability of the half-yearly financial report as of June 30, 2018 _ Erratum Public release - September 21, 2018 The sales breakdown table on page 3 of the half-year financial ...

Clinical Finance: The Most Precious Of The Necessary Evils

Clinical Informatics News | Clinical finance can sometimes be viewed as a necessary evil. Chris Chan, Executive Director, R&D Finance, at Fibrogen, discusses how clinical finance can improve ...

Virbac: Availability of the half-yearly financial report as of June 30, 2018

Virbac: Availability of the half-yearly financial report as of June 30, 2018 Public release - September 17, 2018 Virbac announced today that the 2018 half-yearly financial report is now a...

#jobs #lifescience Manager of Finance and Accounting

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Manager of Finance and Accounting .MA-Boston, INDAF16 Manager of Finance and ...

#jobs #lifescience Senior Accountant – FP&A, Strategic Finance

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Senior Accountant – FP&A, Strategic Finance .MA-Cambridge, Senior ...

#jobs #lifescience Sr. Manager, Finance & Administration

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr. Manager, Finance & Administration .IN-Strawtown, SR. MANAGER, FINANC...

Virbac: Availability of the quarterly financial information as of September 30, 2018

Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is avai...

#jobs #lifescience Finance Assistant (Biotech!)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Finance Assistant (Biotech!) .MA-Cambridge, RESPONSIBILITIES: Kforce has a cl...

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

The dominance of finance in healthcare: political action of unlimited capital in the 21st century.

This article gives, first, a historical account of the action of capital in healthcare in contemporary Brazil and then introduces a debate on the dominance of finance ('financial dominance') in health...

Public-private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya.

The Economic Transition of Health in Africa: A Call for Progressive Pragmatism to Shape the Future of Health Financing.

Abstract-The new financing landscape for the Sustainable Development Goals has a larger emphasis on domestic resource mobilization. But, given the significant role of donor assistance for health, the ...

Can Ethiopia Finance the Continued Development of Its Primary Health Care System If External Resources Decline?

Ethiopia's recent improvements in health outcomes benefited from the large increase in development assistance for health received in recent years, most of which supported its primary care system. Incr...

Carbon pricing of food in Australia: an analysis of the health, environmental and public finance impacts.

To estimate the impact of integrating the price of greenhouse gas emissions into the price of food commodities on dietary and weight-related risk factors and associated disease burden in Australia, as...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV

The high rates of HIV infection in women have brought into sharp focus the problem of violence against women. There is a growing recognition that women and girls' risk of and vulnerability...

The Influence of Significant Weight Lost on the Quality of Voice

The rate of obesity and bariatric surgery is rising steadily. Though Bariatric Surgery Influences on aspects such as endocrin analysis, finance, etc are well tested, quantitative and quali...

Evaluating the Hunger Project in Ghana

The Hunger Project/Epicenter strategy is a community based development strategy that will positively affect health, education, empowerment, and consumption.

Assessing the Preliminary Effects of a Multisectoral Agricultural Intervention on Adolescent Girls' Health

The goal of this study is to understand how the Shamba Maisha household agricultural and economic intervention impacts the sexual, reproductive, and nutritional health of adolescent girls....

Unhealthy Alcohol Drinking and Anesthetic Requirement in Women

Unhealthy alcohol drinking is negatively influencing health of people and costing a large number of annual finance via "secondhand" effects. Additionally, unhealthy alcohol use covers a sp...

Companies [463 Associated Companies listed on BioPortfolio]

Friedli Corporate Finance

Friedli Corporate Finance was started by Peter Friedli in 1986. Since then Peter Friedli has raised Venture Capital from over 80 banks, pension funds and corporations mainly in Switzerland. He has inv...

B. Riley & Co., LLC

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institution...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

International Business Forum

IBF – International Business Forum presents financial and business conferences on venture capital, corporate finance, mergers & acquisitions, corporate strategic investing, defined contribution/401(...

Oxford Venture Finance

Finance for biotech companies.

More Information about "Friedli Corporate Finance" on BioPortfolio

We have published hundreds of Friedli Corporate Finance news stories on BioPortfolio along with dozens of Friedli Corporate Finance Clinical Trials and PubMed Articles about Friedli Corporate Finance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Friedli Corporate Finance Companies in our database. You can also find out about relevant Friedli Corporate Finance Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record